An anti-Haemophilus influenzae type B (HIB) IgG antibody concentration of 0.15 mg/L is generally accepted as the minimum level for protection at a given time, however, it does not confer long-term protection. A study from Finland suggested that the optimum protective level is 1.0 mg/L postimmunization.(2) Furthermore, studies have shown that the response to HIB vaccine is age-related.
By testing pre- and postvaccination patient serum specimens, this test may be used to aid diagnosis of immunodeficiency.